Global CAR T-cell Therapy Drug Market Growth (Status and Outlook) 2022-2028
- LP 4977931
- 88 Pages
- July 2022
- Pharmaceuticals
The United States CAR T-cell Therapy Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global CAR T-cell Therapy Drug market, reaching US$ million by the year 2028. As for the Europe CAR T-cell Therapy Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main CAR T-cell Therapy Drug players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, and J & J, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-cell Therapy Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
CD19-targeted
BCMA-targeted
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Lymphoma
Multiple Myeloma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CAR T-cell Therapy Drug Market Size 2017-2028
2.1.2 CAR T-cell Therapy Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CAR T-cell Therapy Drug Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.3 CAR T-cell Therapy Drug Market Size by Type
2.3.1 CAR T-cell Therapy Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
2.4 CAR T-cell Therapy Drug Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 CAR T-cell Therapy Drug Market Size by Application
2.5.1 CAR T-cell Therapy Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
3 CAR T-cell Therapy Drug Market Size by Player
3.1 CAR T-cell Therapy Drug Market Size Market Share by Players
3.1.1 Global CAR T-cell Therapy Drug Revenue by Players (2020-2022)
3.1.2 Global CAR T-cell Therapy Drug Revenue Market Share by Players (2020-2022)
3.2 Global CAR T-cell Therapy Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-cell Therapy Drug by Regions
4.1 CAR T-cell Therapy Drug Market Size by Regions (2017-2022)
4.2 Americas CAR T-cell Therapy Drug Market Size Growth (2017-2022)
4.3 APAC CAR T-cell Therapy Drug Market Size Growth (2017-2022)
4.4 Europe CAR T-cell Therapy Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa CAR T-cell Therapy Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas CAR T-cell Therapy Drug Market Size by Country (2017-2022)
5.2 Americas CAR T-cell Therapy Drug Market Size by Type (2017-2022)
5.3 Americas CAR T-cell Therapy Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-cell Therapy Drug Market Size by Region (2017-2022)
6.2 APAC CAR T-cell Therapy Drug Market Size by Type (2017-2022)
6.3 APAC CAR T-cell Therapy Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CAR T-cell Therapy Drug by Country (2017-2022)
7.2 Europe CAR T-cell Therapy Drug Market Size by Type (2017-2022)
7.3 Europe CAR T-cell Therapy Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CAR T-cell Therapy Drug by Region (2017-2022)
8.2 Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CAR T-cell Therapy Drug Market Forecast
10.1 Global CAR T-cell Therapy Drug Forecast by Regions (2023-2028)
10.1.1 Global CAR T-cell Therapy Drug Forecast by Regions (2023-2028)
10.1.2 Americas CAR T-cell Therapy Drug Forecast
10.1.3 APAC CAR T-cell Therapy Drug Forecast
10.1.4 Europe CAR T-cell Therapy Drug Forecast
10.1.5 Middle East & Africa CAR T-cell Therapy Drug Forecast
10.2 Americas CAR T-cell Therapy Drug Forecast by Country (2023-2028)
10.2.1 United States CAR T-cell Therapy Drug Market Forecast
10.2.2 Canada CAR T-cell Therapy Drug Market Forecast
10.2.3 Mexico CAR T-cell Therapy Drug Market Forecast
10.2.4 Brazil CAR T-cell Therapy Drug Market Forecast
10.3 APAC CAR T-cell Therapy Drug Forecast by Region (2023-2028)
10.3.1 China CAR T-cell Therapy Drug Market Forecast
10.3.2 Japan CAR T-cell Therapy Drug Market Forecast
10.3.3 Korea CAR T-cell Therapy Drug Market Forecast
10.3.4 Southeast Asia CAR T-cell Therapy Drug Market Forecast
10.3.5 India CAR T-cell Therapy Drug Market Forecast
10.3.6 Australia CAR T-cell Therapy Drug Market Forecast
10.4 Europe CAR T-cell Therapy Drug Forecast by Country (2023-2028)
10.4.1 Germany CAR T-cell Therapy Drug Market Forecast
10.4.2 France CAR T-cell Therapy Drug Market Forecast
10.4.3 UK CAR T-cell Therapy Drug Market Forecast
10.4.4 Italy CAR T-cell Therapy Drug Market Forecast
10.4.5 Russia CAR T-cell Therapy Drug Market Forecast
10.5 Middle East & Africa CAR T-cell Therapy Drug Forecast by Region (2023-2028)
10.5.1 Egypt CAR T-cell Therapy Drug Market Forecast
10.5.2 South Africa CAR T-cell Therapy Drug Market Forecast
10.5.3 Israel CAR T-cell Therapy Drug Market Forecast
10.5.4 Turkey CAR T-cell Therapy Drug Market Forecast
10.5.5 GCC Countries CAR T-cell Therapy Drug Market Forecast
10.6 Global CAR T-cell Therapy Drug Forecast by Type (2023-2028)
10.7 Global CAR T-cell Therapy Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-cell Therapy Drug Product Offered
11.1.3 Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-cell Therapy Drug Product Offered
11.2.3 Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered
11.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-cell Therapy Drug Product Offered
11.4.3 J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-cell Therapy Drug Product Offered
11.5.3 JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-cell Therapy Drug Product Offered
11.6.3 FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
12 Research Findings and Conclusion
Table 1. CAR T-cell Therapy Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CD19-targeted
Table 3. Major Players of BCMA-targeted
Table 4. CAR T-cell Therapy Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 7. CAR T-cell Therapy Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 10. Global CAR T-cell Therapy Drug Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global CAR T-cell Therapy Drug Revenue Market Share by Player (2020-2022)
Table 12. CAR T-cell Therapy Drug Key Players Head office and Products Offered
Table 13. CAR T-cell Therapy Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CAR T-cell Therapy Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global CAR T-cell Therapy Drug Market Size Market Share by Regions (2017-2022)
Table 18. Americas CAR T-cell Therapy Drug Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas CAR T-cell Therapy Drug Market Size Market Share by Country (2017-2022)
Table 20. Americas CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 22. Americas CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 24. APAC CAR T-cell Therapy Drug Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC CAR T-cell Therapy Drug Market Size Market Share by Region (2017-2022)
Table 26. APAC CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 28. APAC CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 30. Europe CAR T-cell Therapy Drug Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe CAR T-cell Therapy Drug Market Size Market Share by Country (2017-2022)
Table 32. Europe CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 34. Europe CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa CAR T-cell Therapy Drug Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of CAR T-cell Therapy Drug
Table 43. Key Market Challenges & Risks of CAR T-cell Therapy Drug
Table 44. Key Industry Trends of CAR T-cell Therapy Drug
Table 45. Global CAR T-cell Therapy Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global CAR T-cell Therapy Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global CAR T-cell Therapy Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Application (2023-2028)
Table 51. Novartis Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 52. Novartis CAR T-cell Therapy Drug Product Offered
Table 53. Novartis CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Gilead Sciences Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 57. Gilead Sciences CAR T-cell Therapy Drug Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Gilead Sciences Latest Developments
Table 61. Bristol-Myers Squibb Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 62. Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered
Table 63. Bristol-Myers Squibb Main Business
Table 64. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bristol-Myers Squibb Latest Developments
Table 66. J & J Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 67. J & J CAR T-cell Therapy Drug Product Offered
Table 68. J & J Main Business
Table 69. J & J CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. J & J Latest Developments
Table 71. JW Therapeutics Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 72. JW Therapeutics CAR T-cell Therapy Drug Product Offered
Table 73. JW Therapeutics Main Business
Table 74. JW Therapeutics CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. JW Therapeutics Latest Developments
Table 76. FOSUNKite Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 77. FOSUNKite CAR T-cell Therapy Drug Product Offered
Table 78. FOSUNKite Main Business
Table 79. FOSUNKite CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. FOSUNKite Latest Developments
List of Figures
Figure 1. CAR T-cell Therapy Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-cell Therapy Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CAR T-cell Therapy Drug Market Size Market Share by Type in 2021
Figure 7. CAR T-cell Therapy Drug in Lymphoma
Figure 8. Global CAR T-cell Therapy Drug Market: Lymphoma (2017-2022) & ($ Millions)
Figure 9. CAR T-cell Therapy Drug in Multiple Myeloma
Figure 10. Global CAR T-cell Therapy Drug Market: Multiple Myeloma (2017-2022) & ($ Millions)
Figure 11. Global CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 12. Global CAR T-cell Therapy Drug Revenue Market Share by Player in 2021
Figure 13. Global CAR T-cell Therapy Drug Market Size Market Share by Regions (2017-2022)
Figure 14. Americas CAR T-cell Therapy Drug Market Size 2017-2022 ($ Millions)
Figure 15. APAC CAR T-cell Therapy Drug Market Size 2017-2022 ($ Millions)
Figure 16. Europe CAR T-cell Therapy Drug Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa CAR T-cell Therapy Drug Market Size 2017-2022 ($ Millions)
Figure 18. Americas CAR T-cell Therapy Drug Value Market Share by Country in 2021
Figure 19. Americas CAR T-cell Therapy Drug Consumption Market Share by Type in 2021
Figure 20. Americas CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 21. United States CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC CAR T-cell Therapy Drug Market Size Market Share by Region in 2021
Figure 26. APAC CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 27. China CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. India CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe CAR T-cell Therapy Drug Market Size Market Share by Country in 2021
Figure 34. Europe CAR T-cell Therapy Drug Market Size Market Share by Type in 2021
Figure 35. Europe CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 36. Germany CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. France CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 44. Egypt CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 50. APAC CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 51. Europe CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 53. United States CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 54. Canada CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 55. Mexico CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 56. Brazil CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 57. China CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 58. Japan CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 59. Korea CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 61. India CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 62. Australia CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 63. Germany CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 64. France CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 65. UK CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 66. Italy CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 67. Russia CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 68. Spain CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 69. Egypt CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 70. South Africa CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 71. Israel CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 72. Turkey CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
